MedTech News

.................... by Andrew Celentano

Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer

BURLINGTON, N.C., Aug. 4, 2026 /PRNewswire/ — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced the nationwide availability of Roche’s VENTANA® PTEN (SP218) RxDx Assay, the first immunohistochemistry (IHC) companion diagnostic test approved by the U.S. Food and Drug Administration (FDA) to determine PTEN protein loss, also known as PTEN deficiency, in tumors of patients with prostate adenocarcinoma. The assay helps identify patients who may be eligible for treatment with AstraZeneca’s TRUQAP® (capivasertib) in combination with abiraterone acetate and prednisone.

Read More »

Skin-like test models could help improve medical devices for people of all skin tones

Many medical devices and wearable health sensors work by shining light into the skin and measuring the signal that returns. These technologies are used in products ranging from pulse oximeters to fitness trackers. However, studies have shown that some optical devices can be less accurate for people with darker skin, raising concerns about health care equity and patient safety. In a recent study reported in the Journal of Biomedical Optics, researchers at the VTT Technical Research Centre of Finland addressed this problem by developing realistic skin-like test models that represent a range of skin tones and include artificial blood vessels with flowing blood-like fluid.

Read More »

Sign up for Blog Updates